Company Profile
Hyphens Pharma International is a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and globally. Its business is organized into Pharmaceutical and Medical Aesthetics.
Its portfolio also includes Proprietary Brands, and Digital Platform and E-Pharmacy segments. The Pharmaceutical and Medical Aesthetics segment markets and sells a range of pharmaceutical and medical aesthetics products Including the Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products in ASEAN countries.
This segment focuses on various therapeutic areas, such as dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics.
Its Proprietary Brands segment develops, markets, and sells dermatological products comprising Ceradan, TDF, and CG210. Its portfolio also includes health supplements under the Ocean Health brand covering areas, such as heart, joint, physical, cognitive, eye, and health, and pharmaceuticals.
The Digital Platform and E-Pharmacy segment operates a digital platform that services procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies primarily in Singapore. Founded in 1998 and headquartered in Singapore, Hyphens Pharma International was formerly known as Hyphens Pharma International Pte Ltd before rebranding in May 2018.